EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Differential regulation of Ca v 3.2 and Ca v 2.2 calcium channels by CB 1 receptors and cannabidiol

Erika K Harding, Ivana A Souza, Maria A Gandini, Vinícius M Gadotti, Md Yousof Ali, Sun Huang, Flavia T T Antunes, Tuan Trang, Gerald W Zamponi iD

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16035 ↗

At a glance

Journal article in British Journal of Pharmacology, 2023. Written by Erika K Harding and 8 co-authors. Institution: Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada. Major MEDLINE topics: Cannabidiol, Chronic Pain, Cannabinoids. Cited 42 times so far (Crossref); 85 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Alberta Innovates, Canadian Institutes of Health Research, Mitacs.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Cannabinoids are a promising therapeutic avenue for chronic pain. However, clinical trials often fail to report analgesic efficacy of cannabinoids. Inhibition of voltage gate calcium (Ca v ) channels is one mechanism through which cannabinoids may produce analgesia. We hypothesized that cannabinoids and cannabinoid receptor agonists target different types of Ca v channels through distinct mechanisms. Experimental Approach Electrophysiological recordings from tsA‐201 cells expressing either Ca v 3.2 or Ca v 2.2 were used to assess inhibition by HU‐210 or cannabidiol (CBD) in the absence and presence of the CB 1 receptor. Homology modelling assessed potential interaction sites for CBD in both Ca v 2.2 and Ca v 3.2. Analgesic effects of CBD were assessed in mouse models of inflammatory and neuropathic pain. Key Results HU‐210 (1 μM) inhibited Ca v 2.2 function in the presence of CB 1 receptor but had no effect on Ca v 3.2 regardless of co‐expression of CB 1 receptor. By contrast, CBD (3 μM) produced no inhibition of Ca v 2.2 and instead inhibited Ca v 3.2 independently of CB 1 receptors. Homology modelling supported these findings, indicating that CBD binds to and occludes the pore of Ca v 3.2, but not Ca v 2.2. Intrathecal CBD alleviated thermal and mechanical hypersensitivity in both male and female mice, and this effect was absent in Ca v 3.2 null mice. Conclusion and Implications Our findings reveal differential modulation of Ca v 2.2 and Ca v 3.2 channels by CB 1 receptors and CBD. This advances our understanding of how different cannabinoids produce analgesia through action at different voltage‐gated calcium channels and could influence the development of novel cannabinoid‐based therapeutics for treatment of chronic pain.

Subjects

MeSH terms (MEDLINE)

CannabidiolChronic PainCannabinoidsMaleFemaleMiceAnimalsCalcium ChannelsAnalgesicsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Dronabinol

Author keywords

CB1 receptorsCav2.2Cav3.2T-type calcium channelcannabidiolcannabinoid receptorvoltage-gated calcium channel

Substances

CannabidiolCalcium ChannelsCannabinoidsAnalgesicsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2HU 211Dronabinol

Authors and institutions

  • Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada.
  • Department of Clinical Neurosciences, and Physiology & Pharmacology, University of Calgary, Calgary, AB, Canada.
  • Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
  • Zymedyne Therapeutics, Calgary, AB, Canada.

ORCID profiles: Gerald W Zamponi

Funding

  • Alberta Innovates
  • Canadian Institutes of Health Research
  • Mitacs

Cite

APA

Harding, E. K., Souza, I. A., Gandini, M. A., Gadotti, V. M., Ali, M. Y., Huang, S., Antunes, F. T. T., Trang, T., & Zamponi, G. W. (2023). Differential regulation of Ca v 3.2 and Ca v 2.2 calcium channels by CB 1 receptors and cannabidiol. British Journal of Pharmacology. https://doi.org/10.1111/bph.16035

Vancouver

Harding EK, Souza IA, Gandini MA, Gadotti VM, Ali MY, Huang S, et al. Differential regulation of Ca v 3.2 and Ca v 2.2 calcium channels by CB 1 receptors and cannabidiol. British Journal of Pharmacology. 2023. doi:10.1111/bph.16035

BibTeX
@article{Harding2023,
  author = {Harding, Erika K and Souza, Ivana A and Gandini, Maria A and Gadotti, Vinícius M and Ali, Md Yousof and Huang, Sun and Antunes, Flavia T T and Trang, Tuan and Zamponi, Gerald W},
  title = {Differential regulation of Ca v 3.2 and Ca v 2.2 calcium channels by CB 1 receptors and cannabidiol},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16035}
}
Start for free →